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Abstract
Background: Total knee arthroplasty is reported to improve the patient’s quality of life and mobility. However loss
of mobility and pain prior to surgery often results in disuse atrophy of muscle. As a consequence the baseline
functional state prior to surgery may result in poorer outcome “post surgery” and extended rehabilitation may be
required. The use of anabolic steroids for performance enhancement and to influence muscle mass is well
established. The positive effects of such treatment on bone and muscle could therefore be beneficial in the
rehabilitation of elderly patients. The purpose of this study was to investigate the effects of small doses of
Nandrolone decanoate on recovery and muscle strength after total knee replacement and to establish the safety of
this drug in multimorbid patients.
Methods: This study was designed as a prospective double blind randomized investigation. Five patients
(treatment group) with a mean age of 66.2 (58-72), average BMI of 30.76 (24.3-35.3) received 50 mg nandrolone
decanoate intramuscular bi-weekly for 6 months. The control group (five patients; mean age 65.2, range 59-72;
average BMI 31.7, range 21.2-35.2) was injected with saline solution. “Pre-operatively” and “post-operatively” (6
weeks, 3,6,9 and 12 months) all patients were assessed using the knee society score (KSS), isokinetic strength
testing and functional tests (a sit-to-stand and timed walking tests). In addition, a bone density scan was used
preoperatively and 6 month postoperatively to assess bone mineral density.
Results: Whilst the steroid group generally performed better than the placebo group for all of the functional tests,
ANOVA failed to reveal any significant differences. The steroid group demonstrated higher levels of quadriceps
muscle strength across the postoperative period which reached significance at 3 (p = 0.02), 6 (p = 0.01), and 12
months (p = 0.02). There was a significant difference for the KSS at 6 weeks (p = 0.02), 6 (p = 0.02) and 12 month
(p = 0.01). The steroid group demonstrated a reduction in the amount of bone mineral density at both the femur
and lumbar spine from “pre-” to “post-surgery”, however, these results did not reach significance (p < 0.05) using
one-way ANOVA.
Conclusions: This project strongly suggests that the use of anabolic steroids result in an improved outcome as
assessed by the KSS and significantly increases extensor strength. No side effects were seen in either the study or
control group.
Trial Registration Number: Regional Health District: Register No. 03.05
Human Research Ethics Committee University: Clearance Number: 04/03-19
Background
Osteoarthritis of the knee is one of the leading causes of
pain and disability for the knee [1]. Total joint replace-
ment is generally accepted as the main treatment for
end-stage osteoarthritis. In fact it has revolutionized the
treatment of disabling arthritis of the lower extremity
[2]. Osteoarthritis of the knee is common and affects
10% of the population aged over 55 [3]. Close to
125.000 procedures were performed in the United States
Medicare population [4] in 1995 and 20.000 were per-
formed in Australia in 2009 [5]. Long term studies on
survivorship use end points such as revision surgery and
reported survival rates between 84% and 98% at
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15 years [6,7]. Whilst patients report an overall
improvement after surgery the benefits after surgery are
most significant for pain and stiffness 3 months after
surgery [8]. Substantial functional improvement using
effect sizes of outcome measures are higher rated by
surgeons whereas patients derived measures showed
effect smaller effect sizes [9]. Muscle strength, especially
quadriceps strength has been shown to be highly corre-
lated with functional performance and undergoes a
decline after surgery [10,11]. Improving postoperative
muscle strength could thus be important to accelerate
recovery and enhance the potential benefits of total
knee arthroplasty [10].
Anabolic steroids have long been used by athletes to
improve their performance [12]. They have potent ana-
bolic effects on the musculoskeletal system, including an
increase in lean body mass, a dose-related hypertrophy
of muscle fibers, and an increase in muscle strength and
mass [13]. The use of anabolic steroids in elderly
patients after knee replacement could therefore have
beneficial effects on postoperative development of mus-
cle strength. This possible may result in faster recovery
and earlier mobilization. In addition anabolic steroids
may have an effect on bone mineral density.
The purpose of this study was to investigate the
effects of small doses of Nandrolone decanoate on
recovery and muscle strength after total knee replace-
ment. A research hypothesis was formulated that there
would be a difference between the group who received
anabolic steroids resulting in faster recovery, higher
muscle strength and increased bone mineral density
compared to the group that only received normal saline
injections.
Methods
Patients were recruited from the department of ortho-
paedic surgery outpatient clinics at a large regional aca-
demic teaching hospital. Prior to participation, all
subjects were familiarized with the procedures and gave
verbal and written informed consent in accordance with
the Human Ethics Research Review Panel of the Univer-
sity and the Regional Health District. The study was
designed as a prospective randomized double-blinded
pilot project.
Inclusion and Exclusion Criteria
Patients aged between 50 and 70 years and monolateral
primary osteoarthritis were recruited. Those with rheu-
matoid arthritis were excluded to avoid the introduction
of confounding variables. Patients where the administra-
tion of Nandrolone could result in severe side effects or
in significant interaction with other drugs and possibly
cause worsening of pre-existing conditions such as pros-
tate hypertrophy were excluded. This also included:
patients with cardiac conditions resulting in chronic
ischaemia and acute coronary syndrome or an ejection
fraction of less than 40%; patients with chronic liver dis-
ease and chronic renal failure; male patients with a
symptomatic hypertrophic benign and malignant pros-
tate, patients on antiepileptic medication such as Val-
proic Acid and Carbamazepine. All patients were
routinely assessed by a specialist physician prior to
enrolment. Recruitment continued until five patients in
each group was achieved.
Randomization
Patients were allocated to either the steroid or control
group by closed envelopes on the first day after surgery
by the research coordinator. Randomization was carried
out by a block of ten envelopes. The protocol was com-
puter generated using an internet based generator
http://www.randomization.com using 2 blocks of ten
with 10 patients per block. This was done in order to
guarantee continuation of randomization in case one of
the patients needed to be excluded within the study
period.
Surgical Protocol
All patients received a combination of regional and gen-
eral anaesthesia. A standard dose of 2 g Cefazolin was
administered prior to anaesthesia. All patients received a
cemented total knee replacement (Stryker® Duracon™)
with a mobile bearing surface through a standard mid-
line skin incision and parapatellar median approach.
Surgery in all patients was performed by a single sur-
geon using a computer navigation system (Stryker®
Navigation) in all cases.
Postoperative Protocol
Postoperatively patients were admitted to the surgical
ward. Cold compression with a Cryo/Cuff (Arthrex) was
used intermittently for 24 hours in all patients. A con-
tinuous passive motion (CPM) machine was used from
the first postoperative day. All patients were mobilized
full weight bearing on day 1 post surgery. Intravenous
antibiotics were continued for 24 hours and subcuta-
neous Enoxiparine (Clexane®) was commenced until dis-
charge. As soon as patients were able to straight leg
raise, flexion to 90 degrees actively was possible and a
safe gait was achieved patients were discharged from the
hospital. Sutures were removed routinely 12 days post-
operative by their general practioner. Further follow up
was performed by an independent examiner at the gait
laboratory of the Musculoskeletal Research Unit of the
University 6 weeks, 3, 6, 9 and 12 month following sur-
gery. All subjects were also tested at this institution the
week prior to surgery. The operating surgeon was only
involved if the patient experienced significant side
effects or complications either resulting from surgery
such as infections, knee effusions or loss of motion.
Patients were visited by the research nurse on day 2 or
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3 after surgery whilst still hospitalized. Procedures were
explained in detail and questions were answered. On
day 5 patients received either 50 mg of Nandrolone
decanoate or the equivalent volume of normal saline as
an intramuscular injection. Patients were then visited
every 2 weeks and injections with either normal saline
or nandrolone was continued for a total of six months.
Outcome Measures
Functional Tests
Sit to Stand Test A modified “sit to stand” and “timed
walking test” as described by Bohannon [14] was per-
formed” pre-operatively” and “post-surgery” as described
earlier. Bohannon [14] measured the time (in seconds)
subjects needed as they stood up and sat down from a
firm padded armless chair of which the seat was 18.5
inches from the ground. We modified the protocol in
consideration that elderly patients after total knee repla-
cement would not be strong enough to repeatedly rise
from a chair within 3 months after surgery. Patients
were asked to stand up and sit down only once from a
firm padded armless chair. Subjects were instructed to
fold their arms across their chests before beginning the
test. Subjects performed one timed trial. The stopwatch
was started after the word “go” and stopped when the
subject returned to the seated position.
Timed Walking Test Speed of ambulation was assessed
via electronic timing gates to record time to perform
two laps between points 10 meters apart. A single set of
gates was used. Subjects walked through the timing
gates, to a marked position 10 meters from the start,
pivoted and walked back. Total time to perform the task
was recorded at two cadences. Initial cadence was at
self-selected speed as described by Pollo et al [15] to
familiarize and warm-up. Three trials were performed at
maximal speed and average values were used for analy-
sis. Subjects were then instructed to walk the same
course at maximum speed. Reliability and responsive-
ness of this test has been demonstrated in healthy
elderly populations [15,16].
Outcome Scores The Knee Society Score (knee and
function scores) was used in all cases. This rating system
was introduced 1989 by Insall etal [17] and has become
the standard evaluation system for reporting results
after total knee replacement surgery. The KSS was
found to have high intra- and interobserver variation
[18,19] and reliable use necessitates evaluation by an
experienced observer. However as this score is still the
most commonly outcome system used and has adequate
construct validity [19] we felt that the use of the rating
system in combination with the other outcome mea-
sures would be sufficient to detect in between group
differences.
Strength Strength of the thigh musculature of the
involved and non-involved limb of each subject was
assessed using a Biodex™ Isokinetik Dynamometer.
Quadriceps and hamstring concentric strength was
determined at 180·s-1. Each subject performed one set of
five maximal extension and flexion repetitions. On each
test occasion the non-involved limb was tested before
the involved limb. Peak torque generated by quadriceps
and hamstring muscles were calculated from the three
best trials. Peak torque was corrected for percentage
bodyweight.
Bone Mineral Density Bone mineral density (BMD)
was measured with dual-energy xray absorptiometry
(DEXA scan) using the LUNAR® system. BMD was mea-
sured the week prior to surgery and repeated at six
month following total knee replacement. DEXA was
performed on the lower spine and neck of femur of the
involved limb. The result was given in g/cm2. The
results were not matched for age, weight, gender and
ethnic origin as the influence of nandrolone on BMD
over the six month interval was the measured variable.
Statistics
Means and standard deviations were calculated for age,
height and mass and for the dependant variables derived
from the functional assessment, quadriceps and ham-
string muscle strength testing, knee society score evalua-
tion and BMD assessment for the nandrolone and
control groups. Independant samples t-tests were used
to compare subject groups for age, height and mass and
the knee society scores at pre-surgery, 3 months,
6 months, 9 months and 12 months. Similarly, an inde-
pendant samples t-test was used to compare the BMD
results at the spine and hip at pre-surgery and
12 months post-surgery. For the functional and the iso-
kinetic tests a repeated measures ANOVA design was
used to compare test limbs of the nandrolone and con-
trol groups across test occasions. Therefore, each
ANOVA included two within factor (test limb: involved
and non-involved and test occasion: pre-surgery,
3 months, 6 months, 9 months and 12 months) and one
between factor (subject group: nandrolone and control).
In the event of a significant (p < 0.05) main effect or
interaction following ANOVA contrasts, post hoc com-
parisons of the means were conducted using the least
significant difference (LSD) test to delineate differences
amongst subject groups or between test limbs. Alpha
level correction using Bonferroni or other such adjust-
ments was not conducted so as to maintain statistical
power. It is recognised that, whilst all the variables were
carefully chosen, they are numerous and hence there is
an increased risk of Type 1 error. However, the cost of
incurring a Type 1 error was deemed minimal and
therefore appropriate given the exploratory nature of
the study. All analyses were conducted using Statistical
Package for Social Sciences (SPSS, Version 12.0.1;
Chicago, IL) for Windows.
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Results
Subject characteristics
Ten patients were included in the study. The study
group included 4 males and 1 female whilst the control
group consisted of 3 males and 2 females. Descriptive
data pertaining to the physical characteristics are pre-
sented in Table 1. Statistical analysis demonstrated no
significant differences between subject groups for age,
height, mass, or body mass index. Therefore, the two
subject groups were considered to be appropriately
matched on the main physical variables.
Knee Society Score
KSS and function scores (mean ± standard deviation) for
the steroid and control groups are presented in Table 2
and 3. The KSS function scores improved across the
post-operative period for both the nandrolone and con-
trol groups. Whilst there was a trend for the nandrolone
group to demonstrate higher function scores, statistical
analysis revealed no significant differences between sub-
ject groups. KSS revealed significant differences (p =
0.02-0.05) between subject groups post surgery except at
3 months where results just failed to reach significance
levels (p = 0.07).
Sit-to-stand
“Sit-to-stand” times (mean ± standard deviation) of the
non-involved and involved limbs of the steroid and con-
trol groups are presented in Table 4. Statistical analysis
revealed no significant main effects or interactions for
the sit-to-stand data. There was, however, a near signifi-
cant (p = 0.06) trend towards faster times for the steroid
group at 9 months post-surgery compared with the con-
trol group.
Timed walk
Walking times (mean ± standard deviation) of the non-
involved and involved limbs of the steroid and control
groups are presented in Table 5. Like the results for the
“sit-to-stand test”, statistical analysis revealed no signifi-
cant main effects or interactions for the walking data.
Nevertheless, whilst the control group demonstrated
only minor improvements throughout the testing cycle
the nandrolone group improved steadily from 6 weeks
to 6 months. At the 9 and 12 month intervals, however,
the walking speed for the nandrolone group approxi-
mated towards the control group.
Quadriceps and hamstring strength
Concentric quadriceps and hamstring isokinetic strength
(mean ± standard deviation) for the non-involved and
involved limbs of the steroid and control groups at
180·s-1 are presented in Table 6 and 7. Statistical analy-
sis of the quadriceps revealed significant between group
differences at three (p = 0.02), six (p = 0.01), and 12
months (p = 0.02). No significant group differences by
test interval interaction were observed for hamstring
strength. Throughout the entire follow-up period the
nandrolone group demonstrated steady improvement in
both quadriceps and hamstring strength. In contrast the
control group improved only minimal and did not reach
pre-operative values for hamstring peak torque.
Bone Mineral Density
Bone mineral density (mean ± standard deviation) at the
femur and spine for the steroid and control groups are
presented in Table 8. None of the subjects demonstrated
abnormal BMD values at any time point during the
study. Bone mineral density at the femur and spine
decreased from pre-surgery to 6 months post-surgery in
both groups. However, the nandrolone group demon-
strated a lower percentage change in BMD at both the
femur and spine (femur: 0.71% versus 3.8%; spine: 1.25%
versus 1.97%). Nevertheless, statistical analysis failed to
identify any significant differences between subject
groups.
Table 1 Demographics of study and control group
Study Control
Height (cm) 173 (158-180) 167 (163-173)
Gender m/f 4/1 3/2
Weight (kg) 91 (71-105) 90 (56-110)
Age (years) 66.2 (58-72) 65.2 (59-72)
BMI (kg/m2) 30.8 (24.3-35.3) 31.7 (21.2-35.2)
Table 2 Knee Society Score
Pre-Op 6 wk 3 m 6 m 9 m 12 m
Study 54.6 (± 9.8) 80.4 (± 8.8) 85.4 (± 7.3) 90.6 (± 5.3) 90.8 (± 5.1) 91.4 (± 3.5)
Control 48.4 (± 2.3) 57.6 (± 10.2) 70.4 (± 9.4) 75.8 (± 11.0) 77 (± 10.6) 81.2 (± 7.1)
p-value 0.28 0.02 0.07 0.04 0.06 0.03
Table 3 Knee Society Function Score

























p-value 0.47 0.37 1.0 0.27 0.27 0.18
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Discussion
The results of this study indicate there are definite ben-
eficial effects of Nandrolone for patients undergoing
knee replacement surgery. The most obvious benefit is
retention and significant improvement of quadriceps
muscle strength as measured by isokinetic testing “pre-”
and “post-operative”.
Total knee replacement is a successful surgical proce-
dure with clinical survivorship of 90 and 94% at 15
years [20] with a reported 85% patient satisfaction rate
[21,22]. The outcome is associated with many factors.
Marked functional limitations, a poor baseline status,
low mental health scores and comorbidity are important
pre-operative predictors [23,24]. Preoperative muscle
strength has been identified to be one of the factors that
influences functional outcome [25]. Patients with
osteoarthritis have quadriceps weakness [22] which per-
sists after surgery. Hsieh et al [26] demonstrated in
patients with rheumatoid arthritis that minor joint
involvement can cause muscle imbalance and joint
instability. Berman et al [25] reported that patients with
near normal quadriceps strength at minimum of 2 years
after surgery had a more normal gait. Silva et al [27]
measured isometric peak torque and found an average
reduction of 30% of both extension and flexion peak
torque. He could also demonstrate that relatively greater
quadriceps strength was associated with a better func-
tional score. Huang et al [28] reported that even after 6-
13 years after surgery muscle balance still existed. Han-
del et al [29] compared a matched healthy group and
found isokinetic muscle strength in patients 3 years
after knee arthroplasty to be reduced by 30%. It may
thus be important to address muscle weakness following
surgery to improve outcome [30]. However there are
only a few studies published assessing strength training
after knee replacement. Rossi et al [31] investigated the
effect of an 8-week resistive training protocol immedi-
ately after surgery and found torque production lower at
30 days post surgery compared to pre-operative levels
but greater at 60 days. Thomas et al [32] used an isoki-
netic pulley system. Isokinetic strength increased to 90%
to that of the unaffected knee within 16 days. Applica-
tion of electric stimulation of the vastus medialis muscle
resulted in a significant improvement in the patient’s
walking speed in a study by Avramidis et al [33].
Anabolic steroids have been used by athletes for half a
century. Most of those athletes self administered high
doses. Effects and side effects of those supraphysiologic
doses are well documented in the literature [34].
Recently [13] there is an increasing interest in using
anabolic steroids for medical conditions such as age
related muscle wasting and increase muscle mass in
patients with secondary wasting syndromes such as
HIV. The main effects are positive anabolic actions on
the musculoskeletal system influencing lean body mass,
muscle size, strength, protein and bone metabolism and
collagen synthesis [13]. The effect is dose dependent
and significant increases in strength occur only with
doses of 300 mg testosterone or more [13]. Side effects
are rare and mostly benign and reversible [35].
The use of anabolic steroids may help to fasten the
recovery of strength and mobility after total knee repla-
cement. Our research has used 50 mg nandrolone
Table 4 Sit to stand test (results in seconds)

























p-value 0.89 0.19 0.20 0.55 0.05 0.11
Table 5 Timed walk test (results in seconds)

























p-value 0.11 0.87 0.16 0.15 0.17 0.65
Table 6 Isokinetik Quadriceps Strength in Nm 180° sec1)
Pre-Op 6 wk 3 m 6 m 9 m 12 m
Study 52.9 (± 14.1) 46 (± 11.0) 76.7 (± 21.9) 77.5 (± 24.4) 78.5 (± 32.2) 80.5 (± 34.9)
Control 49.7 (± 28.9) 39.6 (± 13.9) 47.1 (± 13.5) 55.1 (± 8.0) 63.1 (± 6.0) 55.8 (± 10.3)
p-value 0.78 0.59 0.02 0.01 0.30 0.02
Table 7 Isokinetic Hamstring Strength in Nm (concentric 180° sec1)
Pre-Op 6 wk 3 m 6 m 9 m 12 m
Study 38.9 (± 22.5) 27.1 (± 14.7) 37 (± 18.5) 39.2 (± 12.2) 46.6 (± 26.4) 41.9 (± 23.9)
Control 25.7 (± 14.9) 12.9 (± 10.6) 15.9 (± 11.9) 21.7 (± 14.2) 27.1 (± 11.4) 23.9 (± 8.5)
p-value 0.19 0.22 0.1 0.11 0.18 0.15
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decanoate intramuscularly biweekly which compared to
testosterone has an enhanced anabolic and reduced
androgenic effect. The safe use of this drug in frail
elderly subjects has been demonstrated by Sloan et al
[36]. In our study we have not observed side effects in
any of our patients. However the drug was not self-
administered but injected by an experienced research
nurse. We could demonstrate that patients who received
Nandrolone showed a clear trend towards better func-
tion as measured by the knee society functional score,
functional tests, and a slower decrease of bone mineral
density. Furthermore and more importantly we could
demonstrate significant increases in isokinetic quadri-
ceps peak torque, in the steroid group. This is even of
more significant given the low numbers included in
each group. The knee society score revealed significant
differences after knee replacement between group sub-
jects. In view of the non-significant differences in the
functional tests, this may be due to the low numbers
typical of a pilot project and should be viewed critically.
However it was interesting to see that after cessation of
Nandrolone the study group showed a trend to approxi-
mate to the control group which received normal saline
injections. It could be argued that with the inclusion of
more patients these effects could even be more signifi-
cant. Even though none of those findings reach signifi-
cance levels we have clearly demonstrated a positive
effect of Nandrolone on postoperative recovery and a
significant effect on strength development.
To our knowledge this is the only study investigating
the effect of anabolic steroids after major joint surgery
in a double-blind prospective fashion. Amory et al [37]
has administered supraphysiological doses of testoster-
one enanthate (600 mg imi weekly) for 4 weeks to
patients undergoing knee replacement. He noted a trend
towards improvements in walking and stair climbing
during the postoperative inpatient period. Hedstrom et
al [38] treated women with hip fractures with a combi-
nation of 25 mg nandrolone every third week, vitamin D
and calcium for twelve months and compared it to a
control group receiving only Calcium. He showed that
the nandrolone group despite the application of very
low doses had a significantly higher Harris hip score,
faster gait and demonstrated less bone loss and no loss
of muscle volume measured by quantitative CT.
A decrease in muscle strength mostly pronounced for
the fast twitch type II fibre is a physiological fact [39,40]
and may partially contribute to slower recovery after
major surgery. The application of Nandrolone may thus
only partially compensate for age related changes.
Possible limitations of this study include the introduc-
tion of selection bias. We were possibly unable to select
a true random sample of subjects undergoing knee
arthroplasty. Selecting from a highly motivated subgroup
may have somehow lead to better outcome in both
groups compared to the normal population. However
the double-blind design minimized systemic error and
eliminated observer and experimenter’s bias. Due to the
small number of subjects in each group measurement
error can not be entirely excluded. Random errors and
placebo effects however have most likely been elimi-
nated as those effects would have appeared in both
groups not substantially influencing results.
Conclusions
The results of this research strongly suggest that nandro-
lone results in an improved clinical outcome as assessed
by the knee society score and significantly increases quad-
riceps muscle strength after knee replacement surgery.
A larger study is needed to confirm findings of this pilot
project in order to recommend the general use of low
dose anabolic steroids after joint replacement surgery.
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Table 8 Bone Mineral Density (BMD) in g/cm2 at the femur and spine pre-op and 6 month postoperative
Femur Pre-Op Femur 6 m Post-Op Percentage Bone Loss Spine Pre-Op Spine Post-Op Percentage Bone Loss
Study 0.9246 0.918 -0.71% 1.358 1.341 -1.25%
Control 0.9337 0.898 -3.80% 1.27 1.245 -1.97%
p-value 0.9 0.82 0.19 0.06
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